High-intensity Training Safely Improves Exercise Capacity in Heart, Lung, Kidney, and Liver Transplant Recipients: a Comparative Study

Physical Activity After Organ Transplantation Clinical Trial

Official title:

High-intensity Training Safely Improves Exercise Capacity in Heart, Lung, Kidney, and Liver Transplant Recipients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03329586
• Other study ID #: Exercise in transplantation
• Status: Completed
• Phase: N/A
• First received: October 30, 2017
• Last updated: November 6, 2017
• Start date: August 1, 2013
• Est. completion date: July 31, 2014

Study information

• Verified date: October 2017
• Source: Universitaire Ziekenhuizen Leuven
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators will investigate whether high-intensity exercise training can safely improve physical performance in long-term stable heart, kidney, lung, and liver transplant recipients. Adult transplant recipients will participate in Transplantoux, a 6-month individualized home- and group-based training program, with the goal to cycle the Mont Ventoux in France. The investigators will do cardiopulmonary exercise testing : maximal oxygen consumption, maximal power and BMI.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: July 31, 2014
• Est. primary completion date: June 21, 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• minimum post-transplant period of 6 months

• no acute rejection during the immediately preceding 6 months

Exclusion Criteria:

• patients with cardiovascular or orthopedic contra-indications for intensive physical exercise

Related Conditions & MeSH terms

• Physical Activity After Organ Transplantation

Intervention

Other:
• High-intensity training
6-month individualized home- and group-based training program with the goal to cycle the Mont Ventoux in France

Locations

Country	Name	City	State
Belgium	UZLeuven	Leuven

Sponsors (1)

Lead Sponsor	Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	VO2max	Maximal oxygen consumption	6 months after start training